Prediction of 5-fluorouracil and cisplatin synergism for advanced gastrointestinal cancers using a collagen gel droplet embedded culture

Surgery Today

Volumn 33, Issue 8, 2003, Pages 577-583

  Mori, Shigeru ^a   Kunieda, Katsuyuki ^a   Sugiyama, Yasuyuki ^a   Saji, Shigetoyo ^a  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cisplatin; Collagen gel droplet embedded culture drug sensitivity test; Drug synergism; Fluorouracil; Gastrointestinal cancer

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; AGED; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; DRUG EFFICACY; DRUG POTENTIATION; DRUG SENSITIVITY; FEMALE; GASTROINTESTINAL CARCINOMA; HUMAN; HUMAN CELL; MALE; NICK END LABELING; PREDICTION;

AGED; ANTINEOPLASTIC AGENTS; APOPTOSIS; CISPLATIN; COLLAGEN; DRUG SCREENING ASSAYS, ANTITUMOR; DRUG SYNERGISM; FEMALE; FLUOROURACIL; GASTROINTESTINAL NEOPLASMS; GELS; HUMANS; IN SITU NICK-END LABELING; MALE; MIDDLE AGED; TUMOR CELLS, CULTURED;

EID: 0041701789     PISSN: 09411291     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00595-003-2569-4     Document Type: Article

References (30)

1. Diaz-Rubio E, Aranda E, Martin M, Gonzalez-Mancha R, Gonzalez-Larriba J, Barneto I. Weekly high-dose infusion of 5-fluorouracil in advanced colorectal cancer. Eur J Cancer 1990;26:727-9.
2. Cocconi G, DeLisi V, Di Blasio B. Randomized comparison of 5-FU alone or combined with mitomycin and cytarabine (MFC) in the treatment of advanced gastric cancer. Cancer Treat Rep 1982;66:1263-6.
3. De Lisi V, Cocconi G, Tonato M, Di Costanzo F, Leonardi F, Soldani M. Randomized comparison of 5-FU alone or combined with carmustine, doxorubicin, and mitomycin (BAFMi) in the treatment of advanced gastric cancer: a phase III trial of the Italian Clinical Research Oncology Group (GOIRC). Cancer Treat Rep 1986;70:481-5.
4. Richards FD, Case LD, White DR, Muss HB, Spurr CL, Jackson DV, et al. Combination chemotherapy (5-fluorouracil, methyl-CCNU, mitomycin C) versus 5-fluorouracil alone for advanced previously untreated colorectal carcinoma. A phase III study of the Piedmont Oncology Association. J Clin Oncol 1986;4:565-70.
5. Sekiguchi H, Akiyama S, Fujiwara M, Nakamura H, Kondo K, Kasai Y, et al. Phase II trial of 5-fluorouracil and low-dose cisplatin in patients with squamous cell carcinoma of the esophagus. Surg Today 1999;29:97-101.
6. Johnston PG, Geoffrey F, Drake J, Voeller D, Grem JL, Allegra CJ. The cellular interaction of 5-fluorouracil and cisplatin in a human colon carcinoma cell line. EurJ Cancer 1996;32A:2148-54.
7. Imada T, Rino Y, Takahashi M, Amano T, Kusada O, Kitaura K. In vitro combination effect of 5-fluorouracil and cisplatin on the proliferation, morphology and expression of Ki-67 antigen in human gastric cancer cells. Anticancer Drugs 1997;8:1000-6.
8. Dy C, Gil A, Algarra SM, Aparicio LA, Calvo F, Herranz P. Combination chemotherapy of cisplatin and 5-FU in advanced colorectal carcinoma. Cancer Treat Rep 1986;70:465-8.
9. Kondo K, Murase M, Kodera Y, Akiyama S, Ito K, Yokoyama Y, et al. Feasibility study on protracted infusional 5-fluorouracil and consecutive low-dose cisplatin for advanced gastric cancer. Oncology 1996;53:64-7.
10. Furuhata T, Hirata K, Yamamitsu S, Kimura H, Sasaki K, Hata F, et al. Combination chemotherapy of continuous infusion 5-FU and daily low-dose CDDP in colorectal carcinoma (in Japanese with English abstract). Gan To Kagaku Ryoho (Jpn J Cancer Chemother) 1999;26:1554-8.
11. Scanlon KJ, Newman EM, Lu Y, Priest DG. Biochemical basis for cisplatin and 5-fluorouracil synergism in human ovarian carcinoma cells. Proc Natl Acad Sci USA 1986;83:8923-5.
12. Gross RB, Scanlon KJ. Amino acid membrane transport properties of L1210 cells resistant to cisplatin. Chemioterapia 1986;5:37-43.
13. Shionoya S, Lu Y, Scanlon KJ. Properties of amino acid transport systems in K562 cells sensitive and resistant to cisdiamminedichloroplatinum(II). Cancer Res 1986;46:3445-8.
14. Krebs HA, Hems R, Tyler B. The regulation of folate and methionine metabolism. Biochem J 1976;158:341-53.
15. Andreotti PE, Cree IA, Kurbacher CM, Hartmann DM, Linder D, Harel G, et al. Chemosensitivity testing of human tumors using a microplate adenosine triphosphate luminescence assay: clinical correlation for cisplatin resistance of ovarian carcinoma. Cancer Res 1995;55:5276-82.
16. Link KH, Kornmann M, Leder GH, Butzer U, Pillasch J, Staib L, et al. Regional chemotherapy directed by individual chemosensitivity testing in vitro: a prospective decision-aiding trial. Clin Cancer Res 1996;2:1469-74.
17. Park JG, Kramer BS, Steinberg SM, Carmichael J, Collins JM, Minna JD, et al. Chemosensitivity testing of human colorectal carcinoma cell lines using a tetrazolium-based colorimetric assay. Cancer Res 1987;47:5875-9.
18. Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972;26:239-57.
19. Hickman JA. Apoptosis induced by anticancer drugs. Cancer Metastasis Rev 1992;11:121-39.
20. Kim R, Tanabe K, Inoue H, Toge T. Mechanism(s) of antitumor action in protracted infusion of low dose 5-fluorouracil and cisplatin in gastric carcinoma. Int J Oncol 2002;20:549-55.
21. Hato T, Yasuda K, Rii S, Sugiyama Y, Saji S. Significance and characterization of two cultured cell lines (GSU,GSS), established from gastric cancer patients (in Japanese with English abstract). Biotherapy 1999;13:187-94.
22. Kobayashi H, Tanisaka K, Doi O, Kodama K, Higashiyama M, Nakagawa H, et al. An in vitro chemosensitivity test for solid human tumors using collagen gel droplet embedded cultures. Int J Oncol 1990;8:313-8.
23. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992;119:493-501.
24. Santi DV, McHenry CS. 5-Fluoro-2′-deoxyuridylate: covalent complex with thymidylate synthetase. Proc Natl Acad Sci USA 1972;69:1855-7.
25. Santi DV, McHenry CS, Sommer H. Mechanism of interaction of thymidylate synthetase with 5-fluorodeoxyuridylate. Biochemistry 1974;13:471-81.
26. Armstrong RD, Lewis M, Stern SG, Cadman EC. Acute effect of 5-fluorouracil on cytoplasmic and nuclear dihydrofolate reductase messenger RNA metabolism. J Biol Chem 1986;261:7366-71.
27. Inaba M, Tanaka T, Sawada H. Increased sensitivity to long-term 5-fluorouracil exposure of human colon cancer HT-29 cells resistant to short-term exposure. Jpn J Cancer Res 1998;89:323-7.
28. Ohtani T, Hatori M, Ito H, Takizawa K, Kamijo R, Nagumo M. Involvement of caspases in 5-FU induced apoptosis in an oral cancer cell line. Anticancer Res 2000;20:3117-21.
29. Inaba M, Tashiro T, Sato S, Ohnishi Y, Tanisaka K, Kobayashi H, et al. In vitro-in vivo correlation in anticancer drug sensitivity test using AUC-based concentrations and collagen gel droplet-embedded culture. Oncology 1996;53:250-7.
30. Yagihashi A, Sasaki K, Hirata K, Yamamitsu S. Study of serum CDDP concentrations in patients with advanced or recurrent adeno- or squamous cell carcinoma under combination chemotherapy of 5-FU (CIV) and low-dose CDDP (IV) (in Japanese with English abstract). Gan To Kagaku Ryoho (Jpn J Cancer Chemother) 1996;23:63-7.